Along the same lines, patients with high tumor nuclear ERα(nucl) and high EGFR have significantly reduced progressive free survival (hazard ratio: 4.09) compared to patients with low ERαnucl and low EGFR levels, as estimated with Kaplan-Meier analyses. This evidence concerns the gene EGFR and neoplasm.